Nemaura Medical Inc
OTC:NMRD
Nemaura Medical Inc
OTC:NMRD
Price:
0.0002
USD
Market Closed
Market Cap:
$8.1k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nemaura Medical Inc
OTC:NMRD
|
US |
|
Symbolic Logic Inc
OTC:EVOL
|
US |
|
O
|
Oesterreichische Post AG
VSE:POST
|
AT |
|
scPharmaceuticals Inc
NASDAQ:SCPH
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of NMRD.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NMRD
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
NMRD Competitors Multiples
Nemaura Medical Inc Competitors
Nemaura Medical Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Nemaura Medical Inc
OTC:NMRD
|
3.3m USD | 0 | -0.4 | -0.4 | -0.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
177.7B USD | 4 | 27.2 | 15.6 | 21.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.7B USD | 16 | 56.3 | 42.6 | 52.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.1B USD | 5.1 | 39.2 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.7B USD | 3.1 | 24 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
92.8B USD | 4.6 | 32 | 19 | 25.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.1B USD | 7.8 | 44 | 24.2 | 26.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.6B EUR | 1.7 | 19.2 | 10.8 | 15.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46B USD | 10.7 | 43.5 | 30.8 | 34.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.2B USD | 2 | 25.2 | 10 | 16.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.8B USD | 6.1 | 22.1 | 15.5 | 17.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
